GB1431841A - Ophthalmic-nutritional preparations - Google Patents
Ophthalmic-nutritional preparationsInfo
- Publication number
- GB1431841A GB1431841A GB204373A GB204373A GB1431841A GB 1431841 A GB1431841 A GB 1431841A GB 204373 A GB204373 A GB 204373A GB 204373 A GB204373 A GB 204373A GB 1431841 A GB1431841 A GB 1431841A
- Authority
- GB
- United Kingdom
- Prior art keywords
- vitamin
- acid
- preparations
- opthalmic
- international units
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
1431841 Opthalmic-nutritional preparations S C EVANS 14 Sept 1973 [15 Jan 1973] 2043/ 73 Heading A5B Opthalmic-nutritional preparations to be used independent of or in conjunction with orthoptic therapy which may be in tablet, powder, capsule or liquid form, as an injectable, suppository or as an eye lotion or drop or other pharmaceutical preparations, contain the following nutrients substantially in the following relative quantities per unit dose viz. (a) vitamin A or Retinol 10000 to 60000 international units, (b) Vitamin B, or Thiamine 0.5 mg, (c) Vitamin B2 or Riboflavine 0.5 mg, (d) Vitamin B6 or Pyridoxine 0.5 mg, (e) Vitamin B12 or Cyanocobalamin 0.5 mcg, (f) Vitamin C or ascorbic acid 125 to 2000 mg, (g) Vitamin D or Ergocalciferal 1000 international units, (h) Vitamin E or alpha-tocopheryl 25 to 200 mg, (i) Vitamin K phytomenadione or mendrol sodium diphosphate 1 mg, (j) Folic acid 0.5 mg, (k) Pantothenic acid 5.0 mg, (1) Niacin or Nicotinic acid 7.5 to 20 mg, (m) Para-amino benzoic acid 10 mg, (n) Calcium lactate, Glucoheptonate or pantothenate 200 to 2000 mg, (o) Choline 250 mg, to be taken together with the patient's existing diet. The preparations may be combined with inositol, glucose, additional nutrients and/or minerals e.g. Vitamins A, C, E or PP (nicotinic acid), and/or protein such as dried yeast or milk.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB204373A GB1431841A (en) | 1973-01-15 | 1973-01-15 | Ophthalmic-nutritional preparations |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB204373A GB1431841A (en) | 1973-01-15 | 1973-01-15 | Ophthalmic-nutritional preparations |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1431841A true GB1431841A (en) | 1976-04-14 |
Family
ID=9732617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB204373A Expired GB1431841A (en) | 1973-01-15 | 1973-01-15 | Ophthalmic-nutritional preparations |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1431841A (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657930A (en) * | 1981-10-09 | 1987-04-14 | Baylor College Of Medicine | Mitotic inhibitors preventing posterior lens capsule opacification |
US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
EP0330583A2 (en) * | 1988-02-26 | 1989-08-30 | L'oreal | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
WO1990008548A1 (en) * | 1989-02-02 | 1990-08-09 | Senju Pharmaceutical Co., Ltd. | Liquid preparation for intraocular perfusion |
US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
US5017564A (en) * | 1988-06-03 | 1991-05-21 | Senju Pharmaceutical Co., Ltd. | Solid pharmaceutical preparation and method of producing same |
US5032392A (en) * | 1986-09-04 | 1991-07-16 | Vision Pharmaceuticals | Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes |
WO1992017173A2 (en) * | 1991-04-02 | 1992-10-15 | Jean Berque | Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
EP0595006A1 (en) | 1992-09-14 | 1994-05-04 | Vesta Medicines (Proprietary) Limited | Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
EP0862916A1 (en) * | 1995-11-20 | 1998-09-09 | Kiyoshi Kita | External preparation containing vitamin d or vitamin k |
WO2008086270A2 (en) * | 2007-01-05 | 2008-07-17 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
EP3130335A1 (en) * | 2015-08-13 | 2017-02-15 | Sooft Italia Spa | Ophthalmic composition comprising inositol for improving visual accomodation |
-
1973
- 1973-01-15 GB GB204373A patent/GB1431841A/en not_active Expired
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657930A (en) * | 1981-10-09 | 1987-04-14 | Baylor College Of Medicine | Mitotic inhibitors preventing posterior lens capsule opacification |
US4826871A (en) * | 1985-03-13 | 1989-05-02 | Gressel Philip D | Topical ophthalmic compositions containing one or more retinoids |
US5032392A (en) * | 1986-09-04 | 1991-07-16 | Vision Pharmaceuticals | Aqueous ophthalmic solutions for the treatment of dryness and/or irritation of human or animal eyes |
US4966773A (en) * | 1986-11-25 | 1990-10-30 | Alcon Laboratories, Inc. | Topical ophthalmic compositions containing microfine retinoid particles |
EP0330583A2 (en) * | 1988-02-26 | 1989-08-30 | L'oreal | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
EP0330583B1 (en) * | 1988-02-26 | 1993-08-18 | L'oreal | Method for enhancing the esthetic aspect of the skin with the aid of polyvitaminised mixtures, and cosmetic compositions for its application |
US5017564A (en) * | 1988-06-03 | 1991-05-21 | Senju Pharmaceutical Co., Ltd. | Solid pharmaceutical preparation and method of producing same |
WO1990008548A1 (en) * | 1989-02-02 | 1990-08-09 | Senju Pharmaceutical Co., Ltd. | Liquid preparation for intraocular perfusion |
WO1992017173A2 (en) * | 1991-04-02 | 1992-10-15 | Jean Berque | Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
WO1992017173A3 (en) * | 1991-04-02 | 1993-01-07 | Jean Berque | Use of riboflavin for treating hiv-related diseases, herpes, retinitis pigmentosa and malaria |
EP0595006A1 (en) | 1992-09-14 | 1994-05-04 | Vesta Medicines (Proprietary) Limited | Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12 |
EP0862916A1 (en) * | 1995-11-20 | 1998-09-09 | Kiyoshi Kita | External preparation containing vitamin d or vitamin k |
EP0862916A4 (en) * | 1995-11-20 | 2001-01-10 | Kiyoshi Kita | External preparation containing vitamin d or vitamin k |
US9308264B2 (en) | 2000-11-08 | 2016-04-12 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US9585394B2 (en) | 2000-11-08 | 2017-03-07 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US10064410B2 (en) | 2000-11-08 | 2018-09-04 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
US10595532B2 (en) | 2000-11-08 | 2020-03-24 | Fxs Ventures, Llc | Ophthalmic contact lens solutions containing forms of vitamin B |
WO2008086270A2 (en) * | 2007-01-05 | 2008-07-17 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
WO2008086270A3 (en) * | 2007-01-05 | 2009-08-27 | Fxs Ventures, Llc | Ophthalmic and contact lens solutions containing forms of vitamin b |
EP3130335A1 (en) * | 2015-08-13 | 2017-02-15 | Sooft Italia Spa | Ophthalmic composition comprising inositol for improving visual accomodation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1431841A (en) | Ophthalmic-nutritional preparations | |
AU2506388A (en) | Azelastine-containing medicaments for application in the nose and/or at the eye | |
Suychinov et al. | Vitamins and their role in human body. | |
CA2282082A1 (en) | Microgranules containing cisplatin | |
Toru | A double-blind comparison of sulpiride with chlorpromazine in chronic schizophrenia. | |
GB1464797A (en) | Injectable liquid vitamin preparation | |
GB1437133A (en) | Method for the treatment of ketosis and osteomalacia in cattle | |
Cott | Medicinal plants and dietary supplements: Sources for innovative treatments or adjuncts? | |
US10695369B2 (en) | Cognitive function-remedying agent | |
LEWIS et al. | Agammaglobulinemia associated with pernicious anemia and diabetes mellitus | |
Paul et al. | Urinary cyclic AMP in affective illness | |
CN102579956A (en) | Medicament composition and application thereof | |
US20160038530A1 (en) | Nutritional Supplement to Complement Cancer Therapy | |
Kier et al. | Blood and urine levels in glutethimide (Doriden) intoxication | |
GB1356096A (en) | Mineral salt preparation | |
GHITIS et al. | Availability of milk folate: Studies with cow’s milk in experimental folic acid deficiency | |
US2403473A (en) | Therapeutic compositions | |
JP4553552B2 (en) | Biorhythm application kit | |
US2328355A (en) | Animal growth promoting substance | |
US3168440A (en) | Stable vitamin composition | |
CN102318832A (en) | Nutrition agent for improving body anti-anoxia capability | |
GB1246315A (en) | Pharmaceutical compositions | |
RIVAS et al. | The oral administration of vitamin B12 in tropical sprue | |
GB1118606A (en) | Compositions for the treatment of haemorrhoids | |
SUPPLIED | ADVERSE REACTIONS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19930913 |